雄激素性脱发与新冠病毒奥密克戎变异株感染严重程度的相关性
该横断面研究纳入中国奥密克戎变异株感染患者1837例,其中雄激素性脱发(AGA)921例,评估AGA与新冠感染严重程度(病程、发热、峰值体温、发热持续时间)的相关性。结果显示AGA患者整体症状较轻,AGA与更短的新冠病程和发热持续时间显著相关,且在女性中更明显。感染前规律使用抗雄激素治疗与新冠疾病严重程度无显著相关。
要点
- AGA患者感染奥密克戎后整体症状较非AGA患者轻。
- AGA与更短的新冠病程和发热持续时间显著相关,女性中更明显。
- 感染前规律抗雄激素治疗与新冠严重程度无显著相关。
核心结论
- AGA患者感染奥密克戎变异株后整体新冠症状较非AGA患者轻微。
- AGA与更短的新冠病程和发热持续时间显著相关,且在女性人群中更明显。
- 感染前规律使用抗雄激素治疗与新冠疾病严重程度无显著相关。
研究设计与样本
- 横断面研究,纳入中国奥密克戎变异株感染患者1837例,其中AGA患者921例。
- 新冠严重程度评估考虑新冠病程、发热存在、峰值体温和发热持续时间等因素。
主要发现
- AGA患者整体新冠症状较非AGA患者轻。
- AGA与更短的新冠病程和发热持续时间显著相关,女性中更明显。
- 男性发热风险总体较高(OR=0.784,95%CI=0.622-0.99),但新冠病程较短。
- 感染前规律使用抗雄激素治疗与新冠疾病严重程度无显著相关。
关键数值与推荐
- AGA与更短新冠病程和发热持续时间显著相关,女性中更明显。
- 男性发热风险OR=0.784(95%CI=0.622-0.99)。
临床怎么用
- 对于AGA患者,感染奥密克戎后症状可能相对较轻,但需结合性别等因素综合评估。
- 5α还原酶抑制剂治疗AGA可能不能缓解新冠症状,不应以此为目的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the widespread prevalence of COVID-19, researchers have suggested a potential link between androgens and COVID-19 outcomes. However, the relationship between COVID-19 and androgenetic alopecia (AGA)-a condition strongly influenced by androgens-remains controversial in existing studies. Notably, there is a lack of large-scale clinical studies, particularly concerning data on the Chinese population after infection with the Omicron variant. Therefore, we aimed to investigate the correlation between AGA and severity of COVID-19 infection during the Omicron wave in China. We conducted this cross-sectional study of 1837 patients infected with Omicron variants, including 921 patients with AGA. The assessment of COVID-19 severity considered factors such as COVID-19 duration, the presence of fever, peak body temperature, and the fever duration. The results indicated that patients with AGA experienced milder overall COVID-19 symptoms than non-AGA patients. AGA was significantly associated with a shorter COVID-19 duration and fever duration, with this correlation being more pronounced in the female population. Males generally had a higher risk of fever (OR = 0.784,95% confidence interval = 0.622-0.99) but experienced a shorter COVID-19 duration. The regular use of antiandrogen therapy prior to Omicron infection did not significantly correlate with COVID-19 disease severity, suggesting that 5-alpha reductase inhibitors-treated patients with AGA may not be able to relieve COVID-19 symptoms.
引用
- Lv S, Zou X, Wang L, et al. Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China. J Invest Dermatol. 2024. PMID: 39725159. doi:10.1016/j.jid.2024.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。